Day 1 Recap: Elevate-Derm West 2024

To stay informed with the latest conference insights, subscribe to receive our eNewsletters.

Previewing the 2024 Elevate-Derm West Conference: What to Expect

The conference aimed at providing dermatology NPs and PAs with the latest in the specialty begins today in Scottsdale, Arizona.

POLL: What Topics Are You Looking Forward to at Elevate-Derm West 2024?

Share with us the topics you want to learn more about at Elevate-Derm West.

Kicking Off Elevate-Derm West With Eileen Cheever, MPAS, PA-C

Cheever shared with Dermatology Times her excitement for educational opportunities, networking, and presentations from experts in the specialty.

52-Week Study Reveals Efficacy and Safety of Apremilast for Japanese Patients with Palmoplantar Pustulosis

Apremilast led to a 75% improvement in PPPASI-75 in a significant portion of patients by week 16, with these improvements maintained through week 52.

New Insights into Roflumilast Foam 0.3% for Scalp and Body Psoriasis: ARRECTOR Trial Patient Reported Outcomes

Roflumilast foam 0.3% significantly improved psoriasis severity, symptoms, and quality of life in patients with moderate to severe scalp and body psoriasis.

Experts Present Cases of Complex Pigmented Lesions at Elevate-Derm West

Mark Gimbel, MD, and Whitney High, MD, presented complex cases that underscore the critical need for comprehensive approaches in diagnosing melanocytic lesions.

To view all conference coverage from Elevate-Derm West 2024, click here.